That is very important, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (jeff brown top biotech 2020). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're designed to do. This was a development practically no one discovered. But it's going to have profound implications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment opportunities in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (legacy report prediction). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back perhaps considerably prior to going greater - exponential tech investor. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. future report review. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so many terrific personal companies on the verge of striking the general public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This chance has been developing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers know that tech isn't our usual beat (jeff brown 2021 stock picks). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (jeff brown 1 biotech company). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid growth and producing unbelievable chances for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown 2020 predictions. However in spite of what lots of readers might think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (democratic republic). Losing two months of production and sales truly affects how numerous 5G gadgets are offered in the calendar year. When you think about all of that, selling 250 million systems is exceptional. More importantly, the hold-ups caused by the pandemic created a heap of pent-up demand. And that need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown predictions 2021. And that's not my only 5G prediction When I've talked about 5G in the past, I've described its three different phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services begin to be used (biotech stocks). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase Three by this summer season. This begins something of a virtuous cycle: Many people do not really care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open up a suite of incredible applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a specific niche technology that wasn't well understood. And during that time, there were really just 3 business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is efficiently a greenfield chance.
There's room for numerous companies to exist in this area. what is the legacy report predicting. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can precisely anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is necessary since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced utilizing this innovation. This was among those breakthroughs that practically nobody saw. However it's going to have profound ramifications for curing disease. And, of course, there will be a lot of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe considerably before going higher. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin - exponential tech investor. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff bezos. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date as of February 2021, but we might not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to select winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the marketplace. He's always on the hunt for brand-new opportunities, and he shares much of his finest picks in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted some of the greatest economic occasions of the previous 20 years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it best each time, but Jeff Brown's precise forecasts have actually earned him legions of devoted followers. That says a lot about his ability. The Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study offers a number of research study services with a wide range of specializations - jeff brown tech stock 2021.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown 1 biotech company. On its website, Brownstone says its objective is to provide retail financiers with professional-grade research: "For too long, the finest investment research study has not been readily available to private investors. It has been usually scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. exponential growth. The objective of Brownstone Research study is to make that type of proprietary research study available to any investors looking to gain an edge in the marketplaces. The goal is simple to provide unique and lucrative investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you understand even a bit about the market, you know that he has a reputation as a King Midas of sorts. jeff brown 2021 stock picks. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. genetic sequencing companies jeff brown. could be "the biggest trend of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: expert system and electric automobiles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving vehicles ever. It's nothing except the automobile industry's Holy Grail. As you understand, electric automobiles and self-driving automobile stocks have been substantial this year, however the Wall Street machine has actually approved buzz without much concrete outcome. In spite of an extreme boost in competition over the previous few years, Brown still believes Musk has the very best possibility of putting it all together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transport. Generally, this innovation would permit you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You merely get out of the car and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the profits. It sounds outrageous, however it might be closed than you think.